Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Persica completes first stage of clinical trial on PP-353 for low back pain

Aug. 20, 2021

"Not just the flu" holds for SARS-CoV-2 long-term effects, too

Aug. 19, 2021

Roche discloses new antibacterials

Aug. 19, 2021

Eisai describes new compounds for malaria

Aug. 19, 2021

Assembly Biosciences to advance anti-HBV agent ABI-4334 to the clinic

Aug. 19, 2021

ExeVir's COVID-19 treatment and prophylactic XVR-011 enters clinical study

Aug. 18, 2021

Sirnaomics describes new siRNAs targeting SARS-CoV-2

Aug. 18, 2021

Enanta Pharmaceuticals synthesizes new antiviral compounds

Aug. 18, 2021

Collaboration announced for phase II study of larazotide for COVID-19-derived MIS-C

Aug. 18, 2021

Phase II study cleared to evaluate TQ Formula in COVID-19 patients

Aug. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...